Our estimates are based on published, peer-reviewed clinical trial data.
STEP 1 trial
Semaglutide 2.4mg (Wegovy) was studied in 1,961 adults. Participants lost an average of 14.9% of body weight over 68 weeks.Wilding et al., NEJM 2021
SURMOUNT-1 trial
Tirzepatide 15mg (Mounjaro/Zepbound) was studied in 2,539 adults. The highest dose group lost an average of 20.9% of body weight over 72 weeks.Jastreboff et al., NEJM 2022
SCALE trial
Liraglutide 3.0mg (Saxenda) was studied in 3,731 adults. Participants lost an average of 8.0% of body weight over 56 weeks.Pi-Sunyer et al., NEJM 2015
Clinical trial averages are a starting point. Dose AI tracks your real weight loss, nutrition, medications, and side effects so you can see your personal journey unfold.
Go beyond estimates
Plateau Mode plots your own loss curve against the trial average for your exact medication, so the calculator above becomes a chart you can actually check yourself against.